GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cargo Therapeutics Inc (NAS:CRGX) » Definitions » Scaled Net Operating Assets

Cargo Therapeutics (Cargo Therapeutics) Scaled Net Operating Assets : 0.06 (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Cargo Therapeutics Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Cargo Therapeutics's operating assets for the quarter that ended in Mar. 2024 was $46.52 Mil. Cargo Therapeutics's operating liabilities for the quarter that ended in Mar. 2024 was $21.01 Mil. Cargo Therapeutics's Total Assets for the quarter that ended in Dec. 2023 was $453.04 Mil. Therefore, Cargo Therapeutics's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was 0.06.


Cargo Therapeutics Scaled Net Operating Assets Historical Data

The historical data trend for Cargo Therapeutics's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cargo Therapeutics Scaled Net Operating Assets Chart

Cargo Therapeutics Annual Data
Trend Dec21 Dec22 Dec23
Scaled Net Operating Assets
0.66 -2.91 2.75

Cargo Therapeutics Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only - - -2.76 0.34 0.06

Competitive Comparison of Cargo Therapeutics's Scaled Net Operating Assets

For the Biotechnology subindustry, Cargo Therapeutics's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cargo Therapeutics's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cargo Therapeutics's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Cargo Therapeutics's Scaled Net Operating Assets falls into.



Cargo Therapeutics Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Cargo Therapeutics's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(47.304-19.109)/10.243
=2.75

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=453.036 - 405.732
=47.304

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=47.65 - 26.263 - 2.278
=19.109

Cargo Therapeutics's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2024 )
=(Operating Assets (Q: Mar. 2024 )-Operating Liabilities (Q: Mar. 2024 ))/Total Assets (Q: Dec. 2023 )
=(46.516-21.012)/453.036
=0.06

where

Operating Assets(Q: Mar. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=422.429 - 375.913
=46.516

Operating Liabilities(Q: Mar. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=49.217 - 26.568 - 1.637
=21.012

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cargo Therapeutics Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Cargo Therapeutics's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Cargo Therapeutics (Cargo Therapeutics) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
1900 Alameda De Las Pulgas, Suite 350, San Mateo, CA, USA, 94403
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing strategy are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. Their lead program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

Cargo Therapeutics (Cargo Therapeutics) Headlines